Korea's BL&H To Distribute Swedish Orphan Biovitrum's Orphan Disease Products
This article was originally published in PharmAsia News
Executive Summary
SEOUL - South Korean drug importer and distributor BL&H inked a distribution deal with Swedish Orphan Biovitrum for the latter's two orphan disease products Orfadin and Kepivance in Korea